Oaktree Acquisition Corp. Iii Life Sciences · NASDAQ:OACC
Goldman Sachs Group Inc reported a 6.20% stake in Oaktree Acquisition Corp. Iii Life Sciences (Schedule 13G)
Event Mar 31, 2026 · Filed May 11, 2026
Goldman Sachs Group Inc reported a 6.20% stake in Oaktree Acquisition Corp. Iii Life Sciences, 1,228,500 shares, as a passive investor on Mar 31, 2026. Filed May 11, 2026 (Schedule 13G).
- Stake
- 6.20%
- Shares
- 1,228,500
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| THE GOLDMAN SACHS GROUP, INC. | 6.20% | 1,228,500 |
| GOLDMAN SACHS & CO. LLC | 6.20% | 1,228,500 |
Source
Related
- Oaktree Acquisition Corp. Iii Life Sciences
- Goldman Sachs Group Inc
- Oaktree Acquisition Corp. Iii Life Sciences shareholders
- Schedule 13G/A · Goldman Sachs Group Inc · Aug 12, 2025
- Schedule 13G · Goldman Sachs Group Inc · May 9, 2025
- Form 4 · Oaktree Acquisition Holdings III LS, LLC · Oct 23, 2026
- Schedule 13G · Decagon Asset Management LLP · Aug 14, 2026
- Schedule 13G · Barclays PLC · Aug 13, 2026
- Schedule 13G · Fort Baker Capital Management LP · May 15, 2026
- Schedule 13G/A · Barclays PLC · Feb 11, 2026